Skip to main content
logo

Kerry Holford

Stock Analyst at Berenberg

(1.79)
# 3,313
Out of 5,147 analysts
10
Total ratings
42.86%
Success rate
7.95%
Average return
Main Sectors:
Healthcare
Top Industries:
Drug Manufacturers - General

Stocks Rated by Kerry Holford

Novo Nordisk
Sep 17, 2025
Upgrades: Buy
Price Target: n/a
Current: $37.45
Upside: -
Eli Lilly and Company
Sep 17, 2025
Downgrades: Hold
Price Target: $970 → $830
Current: $1,051.99
Upside: -21.10%